title: Von hippel-lindau disease and erythrocytosis.
authors.affiliation: Istituto di Anatomia Patologica, Università Cattolica, Largo Gemelli 8, 00168 Roma, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Capodimonti
authors.forename: Luciana
authors.initials: L
authors.lastname: Teofili
authors.forename: Maurizio
authors.initials: M
authors.lastname: Martini
authors.forename: Tonia
authors.initials: T
authors.lastname: Cenci
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Iachininoto
authors.forename: Eugenia Rosa
authors.initials: ER
authors.lastname: Nuzzolo
authors.forename: Maria
authors.initials: M
authors.lastname: Bianchi
authors.forename: Marina
authors.initials: M
authors.lastname: Murdolo
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Leone
authors.forename: Luigi M
authors.initials: LM
authors.lastname: Larocca
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000235:genetics; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D004252:DNA Mutational Analysis; D004921:Erythropoietin / Q000097:blood; D020022:Genetic Predisposition to Disease; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D010673:Pheochromocytoma / Q000235:genetics; D018962:Phlebotomy; D011086:Polycythemia / Q000097:blood / Q000235:genetics* / Q000628:therapy; D016896:Treatment Outcome; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics*; D006623:von Hippel-Lindau Disease / Q000097:blood / Q000150:complications / Q000235:genetics*
chemical_list: D000925:Anticoagulants; D015415:Biomarkers; D004921:Erythropoietin; D051794:Von Hippel-Lindau Tumor Suppressor Protein; C497446:VHL protein, human; D001241:Aspirin